Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Public private partnerships: a marriage of necessity.

Rao M.

Cell Stem Cell. 2013 Feb 7;12(2):149-51. doi: 10.1016/j.stem.2013.01.010.

2.

Principles for building public-private partnerships to benefit food safety, nutrition, and health research.

Rowe S, Alexander N, Kretser A, Steele R, Kretsch M, Applebaum R, Clydesdale F, Cummins D, Hentges E, Navia J, Jarvis A, Falci K.

Nutr Rev. 2013 Oct;71(10):682-91. doi: 10.1111/nure.12072. Review.

3.

Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.

Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ, Linden HH, Link A, Muchitsch EM, Wilson CG, Ohrngren P, Dencker L.

Eur J Pharm Sci. 2012 Dec 18;47(5):979-87. doi: 10.1016/j.ejps.2012.09.020. Epub 2012 Oct 6.

PMID:
23046836
4.

The private partners of public health: public-private alliances for public good.

McDonnell S, Bryant C, Harris J, Campbell MK, Lobb A, Hannon PA, Cross JL, Gray B.

Prev Chronic Dis. 2009 Apr;6(2):A69. Epub 2009 Mar 16.

5.

Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).

Hafner J.

J Phys Condens Matter. 2008 Feb 13;20(6):060301. doi: 10.1088/0953-8984/20/06/060301. Epub 2008 Jan 24.

PMID:
21693862
6.

Global strategic partnerships in regenerative medicine.

French A, Suh JY, Suh CY, Rubin L, Barker R, Bure K, Reeve B, Brindley DA.

Trends Biotechnol. 2014 Sep;32(9):436-40. doi: 10.1016/j.tibtech.2014.05.007.

PMID:
25150363
7.

Public-private partnerships in translational medicine: concepts and practical examples.

Luijten PR, van Dongen GA, Moonen CT, Storm G, Crommelin DJ.

J Control Release. 2012 Jul 20;161(2):416-21. doi: 10.1016/j.jconrel.2012.03.012. Epub 2012 Mar 20. Review.

PMID:
22465390
8.

How PEPFAR's public-private partnerships achieved ambitious goals, from improving labs to strengthening supply chains.

Sturchio JL, Cohen GM.

Health Aff (Millwood). 2012 Jul;31(7):1450-8. doi: 10.1377/hlthaff.2012.0585.

9.

The private sector's role in public sector genetically engineered crop projects.

Potrykus I.

N Biotechnol. 2010 Nov 30;27(5):578-81. doi: 10.1016/j.nbt.2010.07.006. Epub 2010 Jul 15. Review.

PMID:
20637908
10.

Academia-industry symbiosis in organic chemistry.

Michaudel Q, Ishihara Y, Baran PS.

Acc Chem Res. 2015 Mar 17;48(3):712-21. doi: 10.1021/ar500424a. Epub 2015 Feb 23.

11.

Challenges for pharmaceutical industry: new partnerships for sustainable human health.

Hunter J.

Philos Trans A Math Phys Eng Sci. 2011 May 13;369(1942):1817-25. doi: 10.1098/rsta.2010.0377. Review.

12.

Harnessing academia, government, and industry.

Tumminia SJ.

Invest Ophthalmol Vis Sci. 2012 May 4;53(5):2515-21. doi: 10.1167/iovs.12-9483q. No abstract available.

PMID:
22562854
13.

Industry's challenge to academia: changing the bench to bedside paradigm.

Fluckiger SL.

Exp Biol Med (Maywood). 2006 Jul;231(7):1257-61.

PMID:
16816131
14.

Improving health with partnerships between academia and industry.

Desmond-Hellmann S.

JAMA Intern Med. 2013 Jun 24;173(12):1051-2. doi: 10.1001/jamainternmed.2013.826. No abstract available.

PMID:
23609423
16.

The role of public-private partnerships in addressing the biomedical innovation challenge.

Said M, Zerhouni E.

Nat Rev Drug Discov. 2014 Nov;13(11):789-90. doi: 10.1038/nrd4438.

PMID:
25359362
17.

The PCAST report: impact and implications for the pharmaceutical industry.

Morris SA, Rosenblatt M, Orloff JJ, Lewis-Hall F, Waldstreicher J.

Clin Pharmacol Ther. 2013 Sep;94(3):300-2. doi: 10.1038/clpt.2013.93.

PMID:
23963216
18.

Effectively managing partnership evolution: a case study from Chicago.

Tishuk BS.

J Bus Contin Emer Plan. 2012 Autumn-2013 Winter;6(2):111-21.

PMID:
23315246
19.

Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.

Zhang Z, Jia M, Wan D.

Int J Health Care Finance Econ. 2009 Jun;9(2):169-82. doi: 10.1007/s10754-009-9063-5. Epub 2009 Apr 10.

PMID:
19360467
20.

Advances in stem cells technologies and their commercialization potential.

Kamarul T.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):363-5. doi: 10.1586/17512433.2013.811804.

PMID:
23927663

Supplemental Content

Support Center